238 related articles for article (PubMed ID: 23018598)
1. Physical and chemical microenvironmental cues orthogonally control the degree and duration of fibrosis-associated epithelial-to-mesenchymal transitions.
Brown AC; Fiore VF; Sulchek TA; Barker TH
J Pathol; 2013 Jan; 229(1):25-35. PubMed ID: 23018598
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of particulate matter and substrate stiffness on epithelial-to-mesenchymal transition.
Barker TH; Dysart MM; Brown AC; Douglas AM; Fiore VF; Russell AG;
Res Rep Health Eff Inst; 2014 Nov; (182):3-41. PubMed ID: 25669020
[TBL] [Abstract][Full Text] [Related]
3. Dasatinib Suppresses TGFβ-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis.
Kanemaru R; Takahashi F; Kato M; Mitsuishi Y; Tajima K; Ihara H; Hidayat M; Wirawan A; Koinuma Y; Hayakawa D; Yagishita S; Ko R; Sato T; Harada N; Kodama Y; Nurwidya F; Sasaki S; Niwa SI; Takahashi K
Lung; 2018 Oct; 196(5):531-541. PubMed ID: 29926178
[TBL] [Abstract][Full Text] [Related]
4. Ligand-independent transforming growth factor-β type I receptor signalling mediates type I collagen-induced epithelial-mesenchymal transition.
DeMaio L; Buckley ST; Krishnaveni MS; Flodby P; Dubourd M; Banfalvi A; Xing Y; Ehrhardt C; Minoo P; Zhou B; Crandall ED; Borok Z
J Pathol; 2012 Mar; 226(4):633-44. PubMed ID: 21984393
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of CARMA3 attenuates the development of bleomycin induced pulmonary fibrosis.
Wu Y; Qi Y; Qiu Z; Chen W
Biochem Biophys Res Commun; 2021 Dec; 581():81-88. PubMed ID: 34656852
[TBL] [Abstract][Full Text] [Related]
6. Protease-activated receptors (PAR)-1 and -3 drive epithelial-mesenchymal transition of alveolar epithelial cells - potential role in lung fibrosis.
Wygrecka M; Didiasova M; Berscheid S; Piskulak K; Taborski B; Zakrzewicz D; Kwapiszewska G; Preissner KT; Markart P
Thromb Haemost; 2013 Aug; 110(2):295-307. PubMed ID: 23739922
[TBL] [Abstract][Full Text] [Related]
7. Directing epithelial to mesenchymal transition through engineered microenvironments displaying orthogonal adhesive and mechanical cues.
Markowski MC; Brown AC; Barker TH
J Biomed Mater Res A; 2012 Aug; 100(8):2119-27. PubMed ID: 22615133
[TBL] [Abstract][Full Text] [Related]
8. Role of epithelial-mesenchymal transition (EMT) and fibroblast function in cerium oxide nanoparticles-induced lung fibrosis.
Ma J; Bishoff B; Mercer RR; Barger M; Schwegler-Berry D; Castranova V
Toxicol Appl Pharmacol; 2017 May; 323():16-25. PubMed ID: 28315692
[TBL] [Abstract][Full Text] [Related]
9. YY1 mediates TGF-β1-induced EMT and pro-fibrogenesis in alveolar epithelial cells.
Zhang C; Zhu X; Hua Y; Zhao Q; Wang K; Zhen L; Wang G; Lü J; Luo A; Cho WC; Lin X; Yu Z
Respir Res; 2019 Nov; 20(1):249. PubMed ID: 31703732
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Transforming Growth Factor-β/Smad-mediated Epithelial-Mesenchymal Transition by Celastrol Provides Protection against Bleomycin-induced Pulmonary Fibrosis.
Divya T; Velavan B; Sudhandiran G
Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):122-129. PubMed ID: 29394529
[TBL] [Abstract][Full Text] [Related]
12. Krüpple-like-factor 4 Attenuates Lung Fibrosis via Inhibiting Epithelial-mesenchymal Transition.
Lin L; Han Q; Xiong Y; Li T; Liu Z; Xu H; Wu Y; Wang N; Liu X
Sci Rep; 2017 Nov; 7(1):15847. PubMed ID: 29158503
[TBL] [Abstract][Full Text] [Related]
13. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
[TBL] [Abstract][Full Text] [Related]
14. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix.
Kim KK; Kugler MC; Wolters PJ; Robillard L; Galvez MG; Brumwell AN; Sheppard D; Chapman HA
Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13180-5. PubMed ID: 16924102
[TBL] [Abstract][Full Text] [Related]
15. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
[TBL] [Abstract][Full Text] [Related]
16. Nintedanib reduces ventilation-augmented bleomycin-induced epithelial-mesenchymal transition and lung fibrosis through suppression of the Src pathway.
Li LF; Kao KC; Liu YY; Lin CW; Chen NH; Lee CS; Wang CW; Yang CT
J Cell Mol Med; 2017 Nov; 21(11):2937-2949. PubMed ID: 28598023
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of msFGFR2c on the epithelial-to-mesenchymal transition of AE2 cells in pulmonary fibrosis.
Jieming G; Liu C; Yang Y; Mo S; Yang X; Wang J
Biotechnol Lett; 2020 Jun; 42(6):1061-1070. PubMed ID: 32130565
[TBL] [Abstract][Full Text] [Related]
18. β-catenin induces A549 alveolar epithelial cell mesenchymal transition during pulmonary fibrosis.
Song P; Zheng JX; Xu J; Liu JZ; Wu LY; Liu C
Mol Med Rep; 2015 Apr; 11(4):2703-10. PubMed ID: 25435076
[TBL] [Abstract][Full Text] [Related]
19. Melatonin prevents pulmonary fibrosis caused by PM
Chen PC; Yen MH; Hsiao SY; Kao WC; Wang MT; Chiou PC; Chao CC
Toxicol Appl Pharmacol; 2024 Jun; 487():116949. PubMed ID: 38688425
[TBL] [Abstract][Full Text] [Related]
20. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation.
Guan R; Wang X; Zhao X; Song N; Zhu J; Wang J; Wang J; Xia C; Chen Y; Zhu D; Shen L
Sci Rep; 2016 Oct; 6():35696. PubMed ID: 27774992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
